414 related articles for article (PubMed ID: 30962764)
1. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
Peng H; Luo X
Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.
Chen Y; Sun J; Hu D; Zhang J; Xu Y; Feng H; Chen Z; Luo Y; Lou Y; Wu H
Cancer Manag Res; 2021; 13():8767-8779. PubMed ID: 34866938
[TBL] [Abstract][Full Text] [Related]
4. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis.
Matsas S; Aguiar PN; Del Giglio A
J Gastrointest Oncol; 2024 Feb; 15(1):33-51. PubMed ID: 38482212
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Inflammatory Indexes as Prognostic Predictors of Survival in Patients Suffering From Synovial Sarcoma.
Cheng Y; Mo F; Pu L; Li Q; Ma X
Front Oncol; 2019; 9():955. PubMed ID: 31608240
[No Abstract] [Full Text] [Related]
10. Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis.
Guan Y; Xiong H; Feng Y; Liao G; Tong T; Pang J
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):220-231. PubMed ID: 32034294
[TBL] [Abstract][Full Text] [Related]
11. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.
Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z
Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.
Zhu Y; Zhou S; Liu Y; Zhai L; Sun X
BMC Cancer; 2018 Apr; 18(1):443. PubMed ID: 29669528
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis.
Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A
Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer.
Karan C; Yaren A; Demirel BC; Dogan T; Ozdemir M; Demiray AG; Taskoylu BY; Degirmencioglu S; Dogu G; Ozhan N; Cakiroglu U; Celikyurek A
Cancer Diagn Progn; 2023; 3(6):706-715. PubMed ID: 37927800
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.
Wang Z; Zhan P; Lv Y; Shen K; Wei Y; Liu H; Song Y
Transl Lung Cancer Res; 2019 Jun; 8(3):214-226. PubMed ID: 31367535
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis.
Liu XB; Gao ZY; Zhang QH; Pandey S; Gao B; Yang F; Tong Q; Li SB
Front Oncol; 2020; 10():178. PubMed ID: 32154173
[No Abstract] [Full Text] [Related]
17. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis.
Peng LP; Li J; Li XF
World J Clin Cases; 2022 Mar; 10(7):2194-2205. PubMed ID: 35321179
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.
Wang Y; Zhang H; Yang Y; Zhang T; Ma X
Front Oncol; 2019; 9():995. PubMed ID: 31649874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
